New product demonstrations, launches and presentations at the 2017 ESCRS in Lisbon.

Posted on 26/09/2017

Rayner announced today it’s schedule of events and opportunities for surgeons during the upcoming ESCRS Congress, on the Rayner booth #P207 (Pavilion 2), which includes the launch of the RayOne Trifocal IOL and a preview of the RayOne Hyd...

Read more

Keeping it simple: The new Rayner website experience

Posted on 22/09/2017

For those of you who have visited the Rayner website over the last few days, you will have noticed we’re now offering a very different online experience; one that we believe is clearer and more user-friendly.

It’s al...

Read more

New patented Trifocal Technology. Rayner set to launch RayOne Trifocal at the upcoming ESCRS

Posted on 14/09/2017

14 September, 2017. Rayner are proud to announce the launch of the newest member of the RayOne® family of preloaded IOLs: the RayOne&re...

Read more

Rayner strengthens commitment to US market with subsidiary Rayner Surgical Inc.

Posted on 7/09/2017

With a large part of 2016 and 2017 focused on European expansion, Rayner announced today its investment into the US market with the establishment of a dedicated subsidiary, ‘Rayner Surgical Inc.’
Based out of New York, Rayner S...

Read more

RayOne Fully Preloaded IOL Injection System. Now available in Brazil.

Posted on 11/07/2017

Rayner announced today the latest update in the RayOne story: registration of the RayOne Aspheric and Spheric monofocal fully preloaded IOL injection systems has been listed in the Federal Register by ANVISA, the Brazilian National Sanitary Sur...

Read more

New RayOne System found best performing in three of four areas covered in Ex-Vivo Study.

Posted on 19/06/2017

An experimental study was recently conducted to compare current fully preloaded intraocular lens (IOL) injection systems on the market. 

The study explored wound architecture after IOL implantation and the overall ease and speed...

Read more

Rayner marks ten years of C-flex in the USA

Posted on 24/04/2017

Rayner will mark an important milestone next month: the 10-year anniversary of US Food and Drug Administration (FDA) approval of C-flex 570C monofocal Intraocular Lens (IOL) for commercial use in the United States of Ame...

Read more

Refractive cataract surgeons in China can now access a Supplementary IOL.

Posted on 27/02/2017

March 02, 2017 – Worthing, United Kingdom. Rayner announced today that a selection of models in their Sulcoflex range of pseudophakic supplementary IOLs have received Chi...

Read more

Restoring sight to the poor and marginalised in Bangladesh: 2016 Report.

Posted on 15/02/2017

In 2016, 773 Rayner IOLs were used to restore the sight of some of Bangladesh’s poorest and most isolated people, according to the recent Annual IMPACT partner report. There were no complications found during post-operative follow up visi...

Read more

Phoenix Equity Partners announces investment in Rayner Surgical Group

Posted on 31/01/2017


Phoenix Equity Partners ("Phoenix"), a leading UK middle-market private equity firm, today announces an investment in Rayner Surgical Group (“Rayner” or “the Company”) alongside the current management team...

Read more